IBTA241220P75000
- 15.05
- +10.57+235.94%
Ibotta Newsroom
Analysts' Top NA Picks: Ibotta, Inc. Class A (IBTA), Astera Labs, Inc. (ALAB)
BofA Securities Maintains Ibotta(IBTA.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Maintains Ibotta(IBTA.US) With Buy Rating, Cuts Target Price to $86
Evercore Maintains Ibotta(IBTA.US) With Buy Rating, Cuts Target Price to $97
Ibotta Is Maintained at Market Outperform by JMP Securities
Ibotta Is Maintained at Buy by Needham
Ibotta Analyst Ratings
JMP Securities Maintains Ibotta(IBTA.US) With Buy Rating, Maintains Target Price $85
Ibotta Downgraded to Neutral From Buy at UBS
Ibotta, Inc.: Strong Q3 Performance and Strategic Partnerships Reinforce Buy Rating Despite Q4 Challenges
JMP Securities Maintains Ibotta(IBTA.US) With Buy Rating, Cuts Target Price to $85
JMP Securities Reaffirms Their Buy Rating on Ibotta, Inc. Class A (IBTA)
Raymond James Maintains Ibotta(IBTA.US) With Buy Rating, Cuts Target Price to $85
Ibotta Is Maintained at Outperform by Raymond James
Wells Fargo Maintains Ibotta(IBTA.US) With Buy Rating, Maintains Target Price $95
Wells Fargo Maintains Ibotta(IBTA.US) With Buy Rating, Raises Target Price to $95
Ibotta, Inc. Class A: Promising Growth and Enhanced Financial Outlook Drive Buy Rating
Ibotta Analyst Ratings
Goldman Sachs Upgrades Ibotta(IBTA.US) to Buy Rating, Cuts Target Price to $87
Ibotta Upgraded to Buy From Neutral at Goldman Sachs